To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
287 Newest Publications in personalized medicinerss
07-05-2013 | Bruce K Lin; Emily Edelman; Joseph D McInerney; James O’Leary; Vaughn Edelson; Kevin S Hughes; Brian D ..., Personalized Medicine, 2013
In the age of genomic medicine, family health history (FHH) remains an important tool for personalized risk assessment as it can inform approaches to disease prevention and management. In primary care, including in prenatal settings, providers recognize that FHH enables them to assess the ...
07-05-2013 | Lidewij Henneman; Carla G van El; Martina C Cornel, Personalized Medicine, 2013
Personalized Medicine , May 2013, Vol. 10, No. 3, Pages 217-219.
07-05-2013 | Edward S Dove; Vural Özdemir, Personalized Medicine, 2013
Personalized Medicine , May 2013, Vol. 10, No. 3, Pages 213-216.
07-05-2013 | Kathryn A Teng; David L Longworth, Personalized Medicine, 2013
Medical care in the USA is plagued by high costs, poor quality and fragmented care delivery. In response, new methods of integrated healthcare delivery are needed, including the patient-centered medical home. At the same time, we need to revitalize our approach to the practice of medicine, ...
07-05-2013 | Won Kim; Phillip G Febbo, Personalized Medicine, 2013
Prostate cancer is the most commonly diagnosed, nondermatologic malignancy in US men. Localized disease can be managed through active surveillance or curative, locally directed therapies, but 30% of men treated with surgery or radiation will need additional (often systemic) treatment for ...
07-05-2013 | Joanne Ngeow; Charis Eng, Personalized Medicine, 2013
Personalized Medicine , May 2013, Vol. 10, No. 3, Pages 231-233.
07-05-2013 | Michael D Graf; Denise F Needham; Nicole Teed; Trisha Brown, Personalized Medicine, 2013
Aim: Health plan coverage policies can influence utilization of genetic tests. Our goal was to characterize the current state of test-related policies from US private payers. Methods: We searched the public websites of 206 insurers for coverage policies. We documented the number of policies, ...
07-05-2013 | Lori A Orlando; Vincent C Henrich; Elizabeth R Hauser; Charles Wilson; Geoffrey S Ginsburg, Personalized Medicine, 2013
As an essential tool for risk stratification, family health history (FHH) is a central component of personalized medicine; yet, despite its widespread acceptance among professional societies and its established place in the medical interview, its widespread adoption is hindered by three major ...
07-05-2013 | Julius Alexander Steffen; Christian Lenz, Personalized Medicine, 2013
Diagnostic testing has been improving the quality of cancer care. The dynamics of this field can be grasped through the application of innovation lifecycle models. Single testing, parallel testing and whole-genome sequencing are major technological evolutions. Given the increasing ...